Ascendia

 

  MARKET NEWS

Zevra’s MIPLYFFA Receives FDA Approval for Use in Patients With Niemann-Pick Disease Type C
European Microbiome Innovation for Health & Microbiome Therapeutics Innovation Group Announce New Collaboration
Assembly Biosciences Reports Positive Interim Phase 1a Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate
Ventyx Biosciences Announces $27-Million Strategic Investment From Sanofi
Hovione & iBET Announce the Establishment of a Venture in Cell & Gene Therapy Solutions
Lonza Launches Innovaform Accelerator, the New Innovation & Formulation Center in Colmar (FR)
Tiziana Life Sciences Announces $4-Million Grant to Study Anti-CD3 in Alzheimer’s Disease
Oncolytics Biotech Reports Favorable Results for BRACELET-1 Breast Cancer Study
PlaqueTec & RxCelerate Collaborate on Early Phase Drug Discovery for Coronary Artery Disease
RSSL Announces Opening of New Laboratory to Provide Advanced 3D Imaging & Metrology Services

  EXPERT CONTENT & RESOURCES

Gelteq: A Breakthrough Ingestible Gel Drug & Nutrient Delivery System

Gelteq: A Breakthrough Ingestible Gel Drug & Nutrient Delivery System

Drug Development & Delivery recently interviewed Nathan Givoni, Co-Founder and CEO of Gelteq, to discuss challenges with traditional drug delivery and the company’s innovative ingestible gel platform designed for drug and nutrient delivery.

BASF Article - Should Developers Choose a Cosmetic or Pharmaceutical-Grade Excipient?

BASF Article - Should Developers Choose a Cosmetic or Pharmaceutical-Grade Excipient?

As regulations continue to change around cosmetic and pharmaceutical-grade excipients, the pharmaceutical industry has choices to make when investing in quality, risk, and public safety.

BASF VIDEO - Formulation Design for Tablets and an Introduction to Your New All-in-One Tableting Solution

BASF VIDEO - Formulation Design for Tablets and an Introduction to Your New All-in-One Tableting Solution

In this video, learn what the formulation and parameter targets are to optimize direct compression formulations, and how to accelerate development with BASF’s new all-in-one fit-for-purpose tableting solution.

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

  FEATURED EDITORIAL

  COMPANY PROFILE

Lifecore Biomedical is a fully integrated Contract Development and Manufacturing Organization (CDMO) with expertise in specialty formulation, aseptic filling, and final packaging of complex medical devices and injectable pharmaceuticals. Lifecore has also been a leading producer of pharmaceutical-grade, non-animal-sourced sodium hyaluronate since 1981 when we developed our fermentation-based process. Since then, we have become the preferred viscoelastic supplier to ophthalmic market leaders and our products have been used in the treatment of more than 150 million patients worldwide. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR - ABISOL Emulsion Preconcentrate Kit & ABISORB-DC Excipient System for Tableting Lipids

WEBINAR - ABISOL Emulsion Preconcentrate Kit & ABISORB-DC Excipient System for Tableting Lipids

ABITEC Technical Business Director, John Tillotson, RPh, PhD, discusses ABITEC’s latest products: The ABISOL Emulsion Preconcentrate kit for the easy formulation of emulsified drug delivery systems and the….

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

Join Quotient Sciences’ experts on July 18 as we explore the latest developments in orally-delivered GLP-1 agonists, the potential for these therapeutics and overcoming the manufacturing challenges.

ON-DEMAND WEBINAR – Solve Common Design Challenges in Inhalation Devices With Porous Polymers

ON-DEMAND WEBINAR – Solve Common Design Challenges in Inhalation Devices With Porous Polymers

The effectiveness of inhalation devices relies on their ability to deliver the pharmaceutical directly to the targeted part of the body with precision and calculated dosing.  Since these devices….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lines blurring between traditional chemical synthesis …

WHITE PAPER: Bring Quality OINDPs to Market Faster Than Ever Before | Proveris Scientific

WHITE PAPER: Bring Quality OINDPs to Market Faster Than Ever Before | Proveris Scientific

The Proveris by Design™ process offers a formalized approach to product development, all the while automating in vitro testing, and streamlining troubleshooting. It is an indispensable tool for successfully developing nasal spray and inhalation drug products as well as critical …

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 2 – Formulation Development
October 9 – Prefilled Syringes